Clinical Trials Browser

Phase 2 × Withdrawn × PT-100 dipeptide × Clear all

NCT00489710 2023-08-22

Talabostat in Treating Patients With Metastatic Kidney Cancer

Phase 2 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms